Zipalertinib

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Zipalertinib
Treatment and conditionWhere it standsTrials
Zipalertinib for carcinomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Zipalertinib for lung diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1